姜黄素
张力素
PTEN公司
蛋白激酶B
癌症研究
PI3K/AKT/mTOR通路
癌细胞
小RNA
生物
激酶
癌症
细胞生物学
信号转导
化学
药理学
基因
生物化学
遗传学
作者
Jiezhong Chen,Xu TieFeng,Chen Chen
出处
期刊:PubMed
日期:2015-12-01
卷期号:3 (21): 330-330
被引量:51
标识
DOI:10.3978/j.issn.2305-5839.2015.09.20
摘要
Curcumin is a well-known phytochemical that has various anti-cancer effects. Although it has been demonstrated that curcumin can inhibit multiple signalling pathways, the exact mechanisms for its demonstrated anti-cancer effects are not fully understood. Recent studies have revealed that curcumin may affect cancer initiation and progression through regulating microRNAs (miRs). In this review, we focus on the roles of microRNA-21 (miR-21) in the anti-cancer effects of curcumin and regulatory mechanisms for the effects of curcumin on miR-21. MiR-21 mediates various effects of curcumin on cancer cells including proliferation, apoptosis, metastasis and anti-cancer drug resistance. Several downstream pathways of miR-21 have been identified including phosphatase and tensin homolog (PTEN)/phosphoinositide 3-kinase/protein kinase B (PI3K/Akt), programmed cell death protein 4 (PDCD4) and NF-κB pathways. Curcumin decreases miR-21 levels through both increasing miR-21 exosome exclusion from the cells and inhibiting the transcription of the miR-21 gene in the cells by binding to its promoter.
科研通智能强力驱动
Strongly Powered by AbleSci AI